Home > Insider Trading > Filing (0000899243-17-027391)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604950	Scpharmaceuticals Inc.	SCPH	Pharmaceutical Preparations (2834)	0331

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1197089	Ltd Industries Pharmaceutical Sun	Sun House, 201 B/1, Western Express Highway, Goregaon (E) Mumbai Maharashtra K7 400063	No	No	Yes	No
1249644	S Dilip Shanghvi	Sun House, 201 B/1, Western Express Highway, Goregaon (E) Mumbai Maharashtra K7 400063	No	No	Yes	No
1717322	B.v. (Netherlands) Pharma Sun	Polarisavenue 87 Hoofddorp P7 2132 JH	No	No	Yes	No
1721949	Sun Pharmaceutical Industries, Inc.	270 Prospect Plains Road Cranbury NJ 08512	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-21	1,810,536	$0.00	1,810,536	No	4	C	Indirect	By Sun Pharmaceutical Industries, Inc.
Common Stock	Acquisiton	2017-11-21	357,143	$14.00	357,143	No	4	P	Indirect	By Sun Pharma (Netherlands) B.V.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Sun Pharmaceutical Industries, Inc.
No	4	P	Indirect	By Sun Pharma (Netherlands) B.V.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2017-11-21	13,000,000	$0.00	1,810,536	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

Represents the total number of shares of Common Stock received by Sun Pharmaceutical Industries, Inc. upon conversion of the Issuer's Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
Sun Pharmaceutical Industries Limited ("Sun Pharma") directly and indirectly owns all shares of Sun Pharmaceutical Industries, Inc., which is the registered owner of the securities. Sun Pharma may be deemed to beneficially own all of the shares of the Issuer held by Sun Pharmaceutical Industries, Inc. Dilip S. Shanghvi is the controlling shareholder of Sun Pharma. Sun Pharma and Mr. Shanghvi disclaim beneficial ownership of the reported shares except to the extent of their respective pecuniary interests therein.
Sun Pharma is the sole shareholder of Sun Pharma (Netherlands) B.V., which is the registered owner of the securities. Sun Pharma may be deemed to beneficially own all of the shares of the Issuer held by Sun Pharma (Netherlands) B.V. Dilip S. Shanghvi is the controlling shareholder of Sun Pharma. Sun Pharma and Mr. Shanghvi disclaim beneficial ownership of the reported shares except to the extent of their respective pecuniary interests therein.
All series of the Issuer's Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 7.180193-for-1 basis on November 21, 2017. The Series B Preferred Stock had no expiration date.